Myocardial Infarction Type 4b in Human Immunodeficiency Virus-Infected Patient
Korean Circulation Journal 2014³â 44±Ç 1È£ p.42 ~ p.44
(Cybula-Walczak Aneta) - Medical University of Warsaw Departments of Hepatology and Acquired Immunodeficiencies
(Szymanski Filip M) - Medical University of Warsaw Departments of Cardiology
(Platek Anna E) - Medical University of Warsaw Departments of Cardiology
(Karpinski Grzegorz) - Medical University of Warsaw Departments of Cardiology
Abstract
We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, enoxaparin) and discharged. After 1.5 months, another STEMI related with in-stent thrombosis took place. The cART scheme was altered, resulting in no further cardiac events in the follow-up period, with undetectable levels of HIV ribonucleic acid. This case highlights the association between HIV infection and the specific drugs of cART, and the risk of cardiovascular disease development.
Å°¿öµå
Human immunodeficiency virus, Myocardial infarction, Antiretroviral therapy
KMID :
0368120140440010042
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)